Furthermore, exposure of primary CLL cells to nutlin-3, a MDM2 inhibitor, induced both NEAT1 and lincRNA-p21 transcription in a p53-dependent manner. Here, CDKN1A is linked to B-cell chronic lymphocytic leukemia.